The role of platinum-based therapy for HER-2-positive breast cancer
Authors:
- 17 February 2006
- journal article
- focus on
- Published by Cambridge University Press (CUP) in Breast Cancer Online
- Vol. 9 (4) , 1-7
Abstract
Trastuzumab is a monoclonal antibody targeting the human epidermal growth factor receptor-2 (HER-2) protein, the mediator of an aggressive breast cancer phenotype. Trastuzumab has an important role in the treatment of metastatic breast cancer (MBC) where it improves multiple endpoints, including overall survival. More recently, striking activity is also seen in non-MBC, with substantial benefits seen in both the neoadjuvant and adjuvant settings. Experimental data has identified synergistic therapeutic effects of platinum containing chemotherapeutic regimens when combined with trastuzumab. We review the pre-clinical and rapidly evolving clinical evidence supporting platinum and trastuzumab combinations for HER-2-positive breast cancer.Keywords
This publication has 37 references indexed in Scilit:
- Randomized Phase II Trial of the Efficacy and Safety of Trastuzumab Combined With Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer Administered As First-Line Treatment: The M77001 Study GroupJournal of Clinical Oncology, 2005
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Clinical Cardiac Tolerability of TrastuzumabJournal of Clinical Oncology, 2004
- Essential Roles of Her2/erbB2 in Cardiac Development and FunctionRecent Progress in Hormone Research, 2004
- Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug ResistanceChemical Reviews, 2003
- Prognostic and predictive value of HER2/neu oncogene in breast cancerMicroscopy Research and Technique, 2002
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/neuOncogeneScience, 1987
- Amplification of a Novel v- erb B-Related Gene in a Human Mammary CarcinomaScience, 1985
- Platinum Compounds: a New Class of Potent Antitumour AgentsNature, 1969
- Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum ElectrodeNature, 1965